Five Prime Therapeutics (FPRX) News Headlines

▮ More

Date

Headline

1/15/2021 6:58:44 AM Five Prime Therapeutics Presents Phase 2 FIGHT Trial Results Of FGFR2b

11/12/2020 10:15:51 PM Five Prime Therapeutics Announces Pricing Of Underwritten Public Offering Of 7.20 Mln Shares At $21.00/shr

11/12/2020 5:45:00 AM Pre-market Movers In Healthcare Sector: IMAC, BNGO, LMNL, FPRX, EQ…

11/11/2020 4:04:00 PM Five Prime Announces Proposed Public Offering Of Common Stock

11/11/2020 9:51:01 AM Stock Alert: Five Prime Skyrockets 300% On Positive Results From Gastric Cancer Treatment Trial

11/11/2020 5:57:18 AM Pre-market Movers In Healthcare Sector: FPRX, ZSAN, IVA, TDOC, INO...

11/11/2020 12:13:25 AM FPRX Takes Flight On FIGHT Data, AGTC To Report XLRP Trial Results, PDSB To Advance COVID-19 Vaccine

10/13/2020 1:47:12 AM ATXI Plunges On Thumbs-down, VYGR's Huntington's Disease Trial On Hold, Deal Or No Deal For SURF?

6/23/2020 4:15:29 AM MYOV To Report SPIRIT 1 Data, EVLO Joins COVID-19 Drug Race, NVTA Loosens Purse Strings

5/19/2020 10:08:39 PM ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth

4/14/2020 9:06:44 AM Five Prime Therapeutics Names Thomas Civik As President And CEO

3/13/2020 9:28:28 AM Five Prime Therapeutics Announces Publication Of The Phase 1 Bemarituzumab Study

2/19/2020 11:18:58 PM FDA Delays Decision On HRTX Drug, KPTI On Watch, ADMP To Resubmit NDA In Q2

2/19/2020 12:17:48 AM BBI Awaits Data In Q2, BLPH Breathes Easy, Big Day For BXRX Tomorrow

12/26/2019 4:19:24 PM Five Prime Therapeutics Announces Resignation Of Lewis Williams From Board Of Directors

11/10/2019 10:48:43 PM LPCN Awaits FDA Word, NKTR On Track, All's Well With Five Prime's FPT155

10/11/2019 5:54:17 AM MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak

10/9/2019 10:02:50 PM 5 Top Gainers In Healthcare Sector (OCGN, CATB, SOLY…)

6/24/2019 4:21:54 PM Five Prime Therapeutics Appoints Lori Lyons-Williams To Its Board Of Directors

5/10/2019 8:42:01 AM Wedbush Is Cutting Five Prime Therapeutics (FPRX) FY19 Rev. Estimate To 23.3 M From 24.0 M